Andrea Wang-Gillam

Andrea Wang-Gillam is a GI oncologist who has integrated wearable monitoring into pancreatic and GI cancer clinical trials to track treatment response and toxicity in real time. Her work has demonstrated that wearable-derived activity and sleep metrics serve as objective digital biomarkers of functional status in advanced cancer patients. She has pioneered the use of continuous monitoring to detect early signs of cachexia and treatment-related decline.